Schedule 13G ownership disclosure

Kura Oncology Inc

Security class unavailable · CUSIP: 50127T109

Event date: 2017-08-11

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,638,461
Percent of class
5.9200%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000930413-17-003002
Form type
SC 13G
Filer
GREAT POINT PARTNERS LLC
CIK
CIK 1281446
Filed
Aug 21, 2017
Reporting period
Aug 11, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub